NovaBridge Biosciences (NBP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for NovaBridge Biosciences, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -25.04x | -0.43x | -0.77x | -0.95x | -9.80x | 44.59x |
| P/B Ratio | 5.02x | 0.34x | 4.62x | 0.79x | 31.95x | 3.73x |
| P/S Ratio | 0.00x | 0.00x | 250.09x | -222.39x | 259.67x | 13.61x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 100.0% | 2325.8% | 47.3% | 100.0% |
| Operating Margin | 0.0% | 0.0% | -11395.1% | 3422.2% | -2353.1% | 10.1% |
| Net Margin | 0.0% | 0.0% | -32674.0% | 23438.9% | -2648.7% | 30.5% |
| EBITDA Margin | 0.0% | 0.0% | -7674.2% | 478.9% | -2337.4% | 10.9% |
| Liquidity | ||||||
| Current Ratio | 8.09x | 20.90x | 5.67x | 5.50x | 7.66x | 9.28x |
| Quick Ratio | 8.09x | 20.90x | 5.67x | 5.62x | 7.62x | 9.28x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.02x | 0.02x | 0.01x | 0.02x | 0.00x |
YoY = year-over-year change. Source: FMP..